EMCURE - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 3.5
| Stock Code | EMCURE | Market Cap | 33,987 Cr. | Current Price | 1,792 ₹ | High / Low | 1,806 ₹ |
| Stock P/E | 51.2 | Book Value | 170 ₹ | Dividend Yield | 0.17 % | ROCE | 13.5 % |
| ROE | 11.6 % | Face Value | 10.0 ₹ | DMA 50 | 1,573 ₹ | DMA 200 | 1,451 ₹ |
| Chg in FII Hold | -0.24 % | Chg in DII Hold | 0.00 % | PAT Qtr | 282 Cr. | PAT Prev Qtr | 118 Cr. |
| RSI | 67.7 | MACD | 44.4 | Volume | 4,84,271 | Avg Vol 1Wk | 6,40,328 |
| Low price | 950 ₹ | High price | 1,806 ₹ | PEG Ratio | -3.77 | Debt to equity | 0.50 |
| 52w Index | 98.4 % | Qtr Profit Var | 462 % | EPS | 33.7 ₹ | Industry PE | 30.2 |
Analyzing EMCURE, the stock shows mixed fundamentals. While profitability has surged (PAT ₹282 Cr. vs ₹118 Cr.), valuation looks stretched with a high P/E (51.2) compared to industry PE (30.2) and a negative PEG ratio (-3.77). Technical indicators (RSI 67.7, MACD strong positive) suggest bullish momentum but also overbought conditions. The current price (₹1,792) is near its 52-week high (₹1,806), limiting upside. Optimal entry would be on a pullback around ₹1,650–1,700. If already holding, consider exiting near ₹1,800–1,820 or if the stock falls below ₹1,700.
✅ Positive
- Strong quarterly PAT growth (₹282 Cr. vs ₹118 Cr.).
- ROCE (13.5%) and ROE (11.6%) show decent efficiency.
- DII holdings stable, providing domestic support.
- EPS of ₹33.7 reflects profitability strength.
⚠️ Limitation
- P/E ratio of 51.2 is significantly higher than industry average (30.2).
- Negative PEG ratio (-3.77) indicates valuation concerns.
- Debt-to-equity ratio at 0.50 is higher than peers, adding financial risk.
- Dividend yield is very low at 0.17%.
📉 Company Negative News
- FII holdings decreased (-0.24%), showing reduced foreign investor confidence.
- High valuation may limit near-term upside.
📈 Company Positive News
- Quarterly PAT surged 462%, showing strong earnings momentum.
- EPS of ₹33.7 supports profitability strength.
- Stock trading near 52-week high, reflecting strong investor sentiment.
🏭 Industry
- Industry PE is 30.2, lower than company PE, suggesting EMCURE trades at a premium.
- Pharmaceutical sector remains resilient, supported by healthcare demand and exports.
🔎 Conclusion
EMCURE is a moderate candidate for swing trading. Strong earnings growth supports momentum, but stretched valuations and overbought technicals increase risk. Entry is favorable on pullbacks near ₹1,650–1,700, with exit targets around ₹1,800–1,820. Traders should maintain strict stop-losses below ₹1,700 to manage downside risk.